Algorithm helps doctors identify more aggressive types of basal cell carcinoma

by Elin Lindström,University of GothenburgCredit: Paul Björkman (Sahlgrenska Universitetssjukhuset)An algorithm can help health care professionals recognize which patients have a highly aggressi

Updated on: July 05,2024

Algorithm helps doctors identify more aggressive types of basal cell carcinoma

by Elin Lindström,University of GothenburgCredit: Paul Björkman (Sahlgrenska Universitetssjukhuset)An algorithm can help health care professionals recognize which patients have a highly aggressi

Updated on:July 05,2024

Preventing breast cancer just got easier. Will more women give these drugs a try?

by Melissa Healy, Los Angeles TimesThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

Updated on: May 05,2024

Preventing breast cancer just got easier. Will more women give these drugs a try?

by Melissa Healy, Los Angeles TimesThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

Updated on:May 05,2024

Researchers expanding the types of cancer CAR-T therapy can target

by Gregory Allen,The ConversationKiller T cells (green and red), or cytotoxic T cells, surround a cancer cell (blue, center). Credit:NICHD/J. Lippincott-Schwartz,CC BY-NC-NDTeaching

Updated on: February 23,2024

Researchers expanding the types of cancer CAR-T therapy can target

by Gregory Allen,The ConversationKiller T cells (green and red), or cytotoxic T cells, surround a cancer cell (blue, center). Credit:NICHD/J. Lippincott-Schwartz,CC BY-NC-NDTeaching

Updated on:February 23,2024

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Updated on: January 22,2024

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Updated on:January 22,2024

Malpractice trends involving active surveillance across cancers

by Cedars-Sinai Medical CenterCredit: CC0 Public DomainActive surveillance is an established practice for managing certain low-risk cancers that are unlikely to cause harm. It is an increasingly

Updated on: March 30,2024

Malpractice trends involving active surveillance across cancers

by Cedars-Sinai Medical CenterCredit: CC0 Public DomainActive surveillance is an established practice for managing certain low-risk cancers that are unlikely to cause harm. It is an increasingly

Updated on:March 30,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on: March 01,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on:March 01,2024

Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

by Shanghai Jiao Tong University Journal CenterCredit:Mechanobiology in Medicine(2023). DOI: 10.1016/j.mbm.2023.100023A new study, led by Prof. Liu from the department of pharmacy, Univers

Updated on: April 30,2024

Extracellular cell matrix stiffness may induce drug resistance of breast cancer cells

by Shanghai Jiao Tong University Journal CenterCredit:Mechanobiology in Medicine(2023). DOI: 10.1016/j.mbm.2023.100023A new study, led by Prof. Liu from the department of pharmacy, Univers

Updated on:April 30,2024

Immune checkpoint blockade prior to surgery promising in multiple cancer types, finds study

byJohns Hopkins University School of MedicineThis graphic highlights the vast scientific research opportunities associated with neoadjuvant immune checkpoint blockade. Credit:Cancer CellTr

Updated on: January 23,2024

Immune checkpoint blockade prior to surgery promising in multiple cancer types, finds study

byJohns Hopkins University School of MedicineThis graphic highlights the vast scientific research opportunities associated with neoadjuvant immune checkpoint blockade. Credit:Cancer CellTr

Updated on:January 23,2024

Researchers unveil inhibition mechanism of receptors on natural killer cells

byUniversity of Science and Technology of ChinaSchematics of GPR34 regulating ILC1 function during tumor progression and suppression. Credit: Prof. Zhou's teamA research team led by Prof. Zh

Updated on: November 09,2024

Researchers unveil inhibition mechanism of receptors on natural killer cells

byUniversity of Science and Technology of ChinaSchematics of GPR34 regulating ILC1 function during tumor progression and suppression. Credit: Prof. Zhou's teamA research team led by Prof. Zh

Updated on:November 09,2024

Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

by University of PittsburghCredit: Unsplash/CC0 Public DomainCertain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, accord

Updated on: February 03,2024

Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

by University of PittsburghCredit: Unsplash/CC0 Public DomainCertain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, accord

Updated on:February 03,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on: April 06,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on:April 06,2024

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs

Updated on: April 07,2024

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs

Updated on:April 07,2024